Key result
Minoxidil-induced pericardial effusion in a patient with end-stage renal disease resolved completely after discontinuation of the drug without requiring drainage.
Case Report (n=1)
In dialysis patients treated with minoxidil, the appearance of a pericardial effusion unresponsive to ultrafiltration should prompt suspicion of drug-induced effusion and immediate withdrawal of the drug.
Alerts clinicians to possible minoxidil-related effusion in ESRD; case report extends sparse data but remains hypothesis-generating.
We present a case of drug-induced pericardial effusion in a patient with end-stage renal disease. Hypertension is frequent among patients with chronic renal failure and sometimes it is necessary to use agents, like minoxidil. Many papers have reported the association between minoxidil and pericardial effusion, both in dialysis patients and those with normal renal function. These effusions sometimes require drainage because of tamponade, but usually disappear after discontinuation of the drug, which is what happened in our patient. In any patient on dialysis treated with minoxidil, the appearance of pericardial effusion unresponsive to ultrafiltration should launch the suspicion of this complication and the drug should be withdrawn.
No takes yet. Share an insight, caveat, or question.
Nautiyal et al. (2010) conducted a case report in End-stage renal disease with drug-induced pericardial effusion (n=1). Minoxidil was evaluated on Resolution of pericardial effusion. Minoxidil-induced pericardial effusion in a patient with end-stage renal disease resolved completely after discontinuation of the drug without requiring drainage.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: